Stay updated on Pembrolizumab vs Placebo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe history shows a new revision entry (v3.4.2) and removal of the previous revision (v3.4.1), a minor bookkeeping update to the record history; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page's revision label in the footer was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedNew revision entry v3.3.4 added and prior revision v3.3.3 removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check91 days agoChange DetectedA new revision (v3.3.2) was added to the record history, and the prior revision (v3.2.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedThe government funding lapse notice at the top of the page has been removed, removing a site-wide advisory about potential delays. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab vs Placebo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.